fbpx

raw data Archives - Omics Help Desk

23andMe Genetic Data – From 2016 to Now

Health

I did my 23andMe test in July 2016, and at the time, I downloaded and did my own analysis of the SNP raw data using different methods. Yesterday, I decided to check if the raw data had changed since that time. It did. I also looked at what’s new with the reports on the web site and found some had changed too.

For example, new in the 2019 report is that “my genetic muscle composition is common in elite power athletes”. That sounds great but I wish I had known it as a child, then I would have perhaps focused on “professional sports”! Last time I checked the report they described the gene differently, as a gene that reveals whether I am a long-distance runner or a sprinter. It shows that although my gene obviously stayed the same, more information about the gene itself was revealed through new scientific studies. I think “elite power athlete” is more motivating!  

Read more

How to validate microbiome testing services now that uBiome got busted?

Uncategorized

When science discovers new links between our health, the bacteria in our gut, what we eat, our brain functions, and our moods, people pay attention. Microbiome research has uncovered those gut-brain-axis links after the National Institutes of Health launched a five-year, $150 million research effort, which in turn gave rise to several microbiome testing and research startups who received hundreds of millions in financing, among them Finch TherapeuticsKallyopeSecond Genome, which research specific diseases, and startups such as uBiomeViomeThryve, DayTwo selling direct-to-consumer testing kits for disease prevention. There is also a public, not-for-profit project called American Gut, which has the lowest price for sequencing people’s microbiome at $99 but is limited in its results. Microbiome testing, like all types of genome sequencing or genomics tests, sequences the DNA (or RNA) of living organisms, bacteria and other microbes in this case.

One of these companies, uBiome, will no longer be included in that list. uBiome raised $83 million in venture capital, and was worth a whopping $600 million at the start of 2019, making the deep dive they took recently to nothing more than a liquidation valuation even more dramatic. After a series of unfortunate events of their own making, uBiome got busted for bad accounting practices, and most recently, for faulty science. It has now filed for Chapter 7 with plans to shut down. As reported by FierceBiotech, CVS stores turned down stocking their shelves with uBiome’s at-home, Explorer microbiome consumer test, after the shocking news were revealed. Two weeks ago, Business Insider reported that uBiome lost their laboratory certifications, forcing them to stop their clinical tests activities. Perhaps worse than the accounting practices are the news that the Explorer test had been tainted by using a reference sequence database that included samples from minors, infants and at least one animal and that was populated by fecal samples volunteered by employees and participants from an online fundraiser.

Read more
Save Filter
×